Chinese researchers have identified a new therapeutic target for Parkinson's disease, a neurodegenerative disorder with high disability and mortality rates, and have successfully discovered a ...

People over the age of 60 are more susceptible to Parkinson's disease. As China's population continues to age, this new medical breakthrough has sparked hope within both the academic and medical ...

Legendary soul singer Jerry Butler, known as "The Iceman," has passed away at 85, leaving behind an unforgettable legacy in ...

Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.

CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs to ...

John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...

Explore AC Immune's innovative Alzheimer's and Parkinson's therapies, key pharma collaborations, and financial outlook. Learn more on ACIU stock here.

Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...

A recent study by Queen Mary University of London suggests that antiepileptic drugs may be linked to an increased risk of ...

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

Dr. Cheng's team continues to explore AI's potential in drug repurposing for neurodegenerative diseases. Their findings suggest that reducing cholesterol, glucose levels and blood pressure through ...